Delaware Wealth Builder A DDIAX

Medalist Rating as of | See Macquarie Investment Hub
  • NAV / 1-Day Return 15.54  /  −0.32 %
  • Total Assets 899.6 Mil
  • Adj. Expense Ratio
    1.060%
  • Expense Ratio 1.060%
  • Distribution Fee Level Average
  • Share Class Type Front Load
  • Category Moderate Allocation
  • Investment Style Large Value
  • Credit Quality / Interest Rate Sensitivity Medium/Moderate
  • Status Open
  • TTM Yield 1.96%
  • Turnover 51%

USD | NAV as of Oct 03, 2024 | 1-Day Return as of Oct 03, 2024, 10:19 PM GMT+0

Morningstar’s Analysis DDIAX

Will DDIAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Delaware Wealth Builder Under Review

null Hyunmin Kim

Hyunmin Kim

Analyst Note

The SEC has fined Macquarie Investment Management, the parent company of Delaware Investments, $80 million, according to a settlement issued on Sept. 19, 2024. The SEC alleges that, between 2017 and 2021, Macquarie improperly valued some illiquid mortgage derivative securities and improperly cross-traded them between private accounts and public mutual funds, primarily to the detriment of the funds. Macquarie noted the involvement of 10 US mutual funds, including Delaware Wealth Builder. The firm agreed to pay the fine without admitting or denying any wrongdoing. In view of these developments, we are placing the fund Under Review.

Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings DDIAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 18.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Apple Inc

2.82 25.3 Mil
Technology

NVIDIA Corp

2.75 24.8 Mil
Technology

Microsoft Corp

2.73 24.6 Mil
Technology

iShares Core MSCI Emerging Markets ETF

2.10 18.9 Mil

Vanguard S&P 500 ETF

1.75 15.7 Mil

iShares Core MSCI Europe ETF

1.69 15.2 Mil

United States Treasury Notes 4.375%

1.53 13.8 Mil
Government

Exxon Mobil Corp

1.20 10.8 Mil
Energy

Sc Hixson Llc Pp

1.14 10.3 Mil

Merck & Co Inc

1.03 9.3 Mil
Healthcare

Sponsor Center